RICHMOND, Va. (WRIC) — Presidential Candidate Hillary Clinton has been prescribed the controversial drug Levaquin, a drug 8News has exposed to cause serious permanent damage in some cases — including problems with the central nervous system.
That prompted the FDA in May to issue a new warning about the drug, which is part of a group of powerful antibiotics known as fluoroquinolones. Clinton has been advised to take the drug for 10 days for her pneumonia.
For more than year, 8News has reported on patients who say these drugs have left them with permanent pain
At an FDA hearing about the drugs, Mark Girard told 8News, “within days of starting the Levaquin, I completely lost control of my bladder, I had blot clot.”
Rachel Brummert, who has led an effort to warn the public about Levaquin, added, “within a month of taking Levaquin I ruptured my first tendon, it was my Achilles tendon, and in last 9 years I have ruptured 10 tendons.”
In May, the FDA responded by issuing new label changes for the drugs, stating the antibiotics have been associated with disabling and potentially irreversible adverse reactions including tendon ruptures and problems with the central nervous system.
Meanwhile, as candidate health takes center stage, Donald Trump surprises Doctor Oz on Thursday with his physical results.
“Your BMI is high,” Dr. Oz said as he reviewed Trumps records.
He went on to tells Trump he could lose some weight – to which Trump agreed – but also said that Trump is in good health for a man his age.
Meanwhile, many patient advocacy groups are speaking out about the drugs Clinton has been given. The Quinolone Vigilance Foundation says the adverse effects from these drugs do not discriminate and can affect anyone at any time.
The QVF issued this statement:
We are concerned about anyone who is prescribed a fluoroquinolone antibiotic such as Levaquin, Cipro, and Avelox. They can be associated with severe, often permanent, adverse events and should be reserved for the most serious, life threatening conditions for which there are no safer alternatives. Fluoroquinolone adverse effects do not discriminate and can affect anyone at any time.
While recent labeling changes from the Food and Drug Administration (FDA) on fluoroquinolone antibiotics are a big step in the right direction, the news of Secretary Clinton being prescribed Levaquin will hopefully start a national conversation highlighting the need for full disclosure of risks, contraindications, and about the over-prescribing of antibiotics leading to antibiotic resistance.
We wish Secretary Clinton a full recovery with no adverse effects from the use of Levaquin.